Kakamega leads in daily COVID-19 infections as MoH announces 714 new cases
The Ministry of Health has announced an 11.8 percent COVID-19 positivity rate in the country, following 714 new infections tested from 6,039 samples announced on Saturday.
Kakamega had the highest number of new infections at 79 while Kisii and Migori came second and third with 78 and 76 new infections respectively.
In the last one day, 74 new cases have been recorded in Nairobi while 72, 69 and 60 cases have been recorded in Kisumu, Busia and Siaya counties.
In a statement to the Press, the Health Ministry said the new infections had pushed the tally of confirmed cases so far to 178,792 and the total number of samples tested to 1,901,067.
From the cases, 705 are Kenyans while 9 are foreigners; 396 are males and 318 females.
A total of 1,073 patients are currently admitted in various health facilities countrywide, while 5,174 patients are under Home Based Isolation and Care program.
94 patients are in the Intensive Care 6 Unit (ICU), 25 of whom are on ventilatory support and 50 on supplemental oxygen.
19 patients are under observation.
The youngest patient is a two-month-old infant while the oldest is 94 years.
The new infections are distributed by age as follows: 0-9 years (34), 10-19 years (44), 20-29 years (140), 30-39 (180) 40-49 (126) 50-59 (86) 60 years and above (104).
Meanwhile, 285 patients have recovered from the disease in the last one day; 167 from various health facilities across the country and 118 from the Home Based and Isolation Care program.
So far, 122,631 people have recovered; 88,904 from the Home Based Care and Isolation program, and 33,727 from various health facilities.
At the same time, the country’s total coronavirus death toll has hit 3,447 after 10 new deaths were reported on Saturday.
“All of them were late deaths reported after conducting Facility Record Audits on diverse dates in the months of April, May and June,” MoH said on Saturday.
For Citizen TV updates
Join @citizentvke Telegram channel
Video Of The Day: KEMRI scientists examine safety of anti-malarial drugs in first trimester of pregnancy